Iniprazol may be available in the countries listed below.
Ingredient matches for Iniprazol
Lansoprazole is reported as an ingredient of Iniprazol in the following countries:
- Tunisia
International Drug Name Search
Iniprazol may be available in the countries listed below.
Lansoprazole is reported as an ingredient of Iniprazol in the following countries:
International Drug Name Search
Ketocid may be available in the countries listed below.
UK matches:
Ketoprofen is reported as an ingredient of Ketocid in the following countries:
International Drug Name Search
Glossary
SPC | Summary of Product Characteristics (UK) |
In the US, Potassium Citrate (potassium citrate systemic) is a member of the drug class urinary pH modifiers and is used to treat Nephrolithiasis and Renal Tubular Acidosis.
US matches:
Ph. Int.
A12BA02
0006100-05-6
C6-H5-K3-O7·H2O
324
Alkalinizer
Treatment of dehydration
Treatment of potassium deficiency
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tripotassium salt monohydrate (USP)
2-Hydroxy-1,2,3-propanetricarboxylic acid tripotassium citrate monohydrate
Tripotassium 2-hydroxy-1,2,3-propanetricarboxylate monohydrate (Ph. Int.)
Tripotassium 2-hydroxypropane-1,2,3-tricarboxylate monohydrate (Ph. Eur.)
Tripotassium citrate monohydrate (Ph. Int.)
International Drug Name Search
Glossary
IS | Inofficial Synonym |
PH | Pharmacopoeia Name |
Ph. Eur. | European Pharmacopoeia |
Ph. Int. | Pharmacopoea Internationalis |
USP | Pharmacopoeia of the United States |
Helposteol may be available in the countries listed below.
Alfacalcidol is reported as an ingredient of Helposteol in the following countries:
International Drug Name Search
Ivotan may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ivermectin is reported as an ingredient of Ivotan in the following countries:
International Drug Name Search
Pressodipin may be available in the countries listed below.
Nitrendipine is reported as an ingredient of Pressodipin in the following countries:
International Drug Name Search
Calidiol may be available in the countries listed below.
Estradiol is reported as an ingredient of Calidiol in the following countries:
Estradiol hemihydrate (a derivative of Estradiol) is reported as an ingredient of Calidiol in the following countries:
International Drug Name Search
Salbron may be available in the countries listed below.
Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Salbron in the following countries:
International Drug Name Search
Fluconazole Pliva may be available in the countries listed below.
Fluconazole is reported as an ingredient of Fluconazole Pliva in the following countries:
International Drug Name Search
Nurofen for children may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Nurofen for children in the following countries:
International Drug Name Search
Ethinylestradiol is reported as an ingredient of Taortho Cyclen-21 in the following countries:
Norgestimate is reported as an ingredient of Taortho Cyclen-21 in the following countries:
International Drug Name Search
Twynsta is a brand name of amlodipine/telmisartan, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Twynsta available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Twynsta. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
Tensium may be available in the countries listed below.
Alprazolam is reported as an ingredient of Tensium in the following countries:
International Drug Name Search
Staxim may be available in the countries listed below.
Cefuroxime axetil (a derivative of Cefuroxime) is reported as an ingredient of Staxim in the following countries:
International Drug Name Search
In the US, Pegademase Bovine (pegademase bovine systemic) is a member of the drug class other immunostimulants.
US matches:
Pegademase Bovine (USAN) is also known as Pegademase (Rec.INN)
International Drug Name Search
Glossary
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Chinofungin may be available in the countries listed below.
Tolnaftate is reported as an ingredient of Chinofungin in the following countries:
International Drug Name Search
Celin may be available in the countries listed below.
Ascorbic Acid is reported as an ingredient of Celin in the following countries:
International Drug Name Search
Glemicid may be available in the countries listed below.
Glibenclamide is reported as an ingredient of Glemicid in the following countries:
International Drug Name Search
Treating high blood pressure and chronic stable angina (chest pain). It may be used alone or in combination with other medicines. It may also be used for other conditions as determined by your doctor.
Diltia XT 24-Hour Sustained-Release Capsules are a calcium channel blocker. It works by relaxing (dilating) your blood vessels, lowering blood pressure, and decreasing heart rate, which lowers the workload of the heart. It also dilates coronary arteries, which increases blood flow to the heart.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Diltia XT 24-Hour Sustained-Release Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Diltia XT 24-Hour Sustained-Release Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Diltia XT 24-Hour Sustained-Release Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Diltia XT 24-Hour Sustained-Release Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Diltia XT 24-Hour Sustained-Release Capsules.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Constipation; dizziness; facial flushing; headache; lightheadedness; tiredness; weakness.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); chest pain; fainting; fast, slow, or irregular heartbeat; fever, chills, or sore throat; hallucinations; mental or mood changes; personality changes; reddened, blistered, or swollen skin; severe or persistent dizziness, lightheadedness, nausea, or vomiting; shortness of breath; sudden weight gain; swelling of the feet, ankles, or hands; symptoms of liver problems (eg, dark urine, pale stools, yellowing of the skin or eyes); tender, bleeding, or swollen gums; unusual bleeding or bruising; unusual or persistent tiredness or weakness; vision changes.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Diltia XT side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include confusion; difficulty breathing, especially when lying down; dizziness; drowsiness; fainting; lightheadedness, especially when standing; loss of consciousness; nausea; nervousness; slurred speech; unusual weakness; very slow heart rate.
Store Diltia XT 24-Hour Sustained-Release Capsules at room temperature, between 59 and 77 degrees F (15 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Diltia XT 24-Hour Sustained-Release Capsules out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Diltia XT 24-Hour Sustained-Release Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Fluconazol Mayrhofer may be available in the countries listed below.
Fluconazole is reported as an ingredient of Fluconazol Mayrhofer in the following countries:
International Drug Name Search
In the US, Methacholine (methacholine systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Diagnosis and Investigation.
US matches:
0000055-92-5
C8-H18N-O2
160
Parasympathomimetic agent, direct acting
1-Propanaminium, 2-(acetyloxy)-N,N,N-trimethyl-
1-Propanaminium, 2-(acetyloxy)-N,N,N-trimethyl-, chloride
International Drug Name Search
Glossary
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Pivalone compositum may be available in the countries listed below.
Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Pivalone compositum in the following countries:
Tixocortol 21-pivalate (a derivative of Tixocortol) is reported as an ingredient of Pivalone compositum in the following countries:
International Drug Name Search
Nexotensil may be available in the countries listed below.
Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Nexotensil in the following countries:
International Drug Name Search
Bicalutamid Billix may be available in the countries listed below.
Bicalutamide is reported as an ingredient of Bicalutamid Billix in the following countries:
International Drug Name Search
Cipronex may be available in the countries listed below.
Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Cipronex in the following countries:
International Drug Name Search
Relieving symptoms of sinus congestion, pressure, runny nose, and sneezing due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.
Bromhist Pediatric Drops are an antihistamine and decongestant combination. The antihistamine works by blocking the action of histamine, which helps reduce symptoms such as watery eyes and sneezing. The decongestant promotes sinus and nasal drainage, which relieves congestion and pressure.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Bromhist Pediatric Drops. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Bromhist Pediatric Drops. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Bromhist Pediatric Drops may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Bromhist Pediatric Drops as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Bromhist Pediatric Drops.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Constipation; diarrhea; dizziness; drowsiness; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.
Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating or inability to urinate; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; tremor; trouble sleeping; vision changes.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Bromhist Pediatric side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; vomiting.
Store Bromhist Pediatric Drops at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Bromhist Pediatric Drops out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Bromhist Pediatric Drops. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Levoferin may be available in the countries listed below.
Levodropropizine is reported as an ingredient of Levoferin in the following countries:
International Drug Name Search
Emilok may be available in the countries listed below.
Omeprazole is reported as an ingredient of Emilok in the following countries:
International Drug Name Search
Novolin 10R may be available in the countries listed below.
Insulin Injection, Biphasic Isophane human (a derivative of Insulin Injection, Biphasic Isophane) is reported as an ingredient of Novolin 10R in the following countries:
International Drug Name Search
Farbutamol may be available in the countries listed below.
Salbutamol is reported as an ingredient of Farbutamol in the following countries:
International Drug Name Search
Atoris may be available in the countries listed below.
Atorvastatin is reported as an ingredient of Atoris in the following countries:
Atorvastatin calcium (a derivative of Atorvastatin) is reported as an ingredient of Atoris in the following countries:
International Drug Name Search
Topiramat Migräne Stada may be available in the countries listed below.
Topiramate is reported as an ingredient of Topiramat Migräne Stada in the following countries:
International Drug Name Search
Diclofenackalium may be available in the countries listed below.
Diclofenac potassium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofenackalium in the following countries:
International Drug Name Search
Dolobene Hot may be available in the countries listed below.
Capsaicin is reported as an ingredient of Dolobene Hot in the following countries:
International Drug Name Search
Cloracef may be available in the countries listed below.
Cefaclor is reported as an ingredient of Cloracef in the following countries:
International Drug Name Search
Gentamicin WZF Polfa may be available in the countries listed below.
Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Gentamicin WZF Polfa in the following countries:
International Drug Name Search
Ceftazidima may be available in the countries listed below.
Ceftazidima (DCIT) is known as Ceftazidime in the US.
International Drug Name Search
Glossary
DCIT | Denominazione Comune Italiana |
In some countries, this medicine may only be approved for veterinary use.
Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Neomed in the following countries:
International Drug Name Search
Stapin may be available in the countries listed below.
Felodipine is reported as an ingredient of Stapin in the following countries:
International Drug Name Search
Piperacillina DOC may be available in the countries listed below.
Piperacillin sodium salt (a derivative of Piperacillin) is reported as an ingredient of Piperacillina DOC in the following countries:
International Drug Name Search
Bactesul may be available in the countries listed below.
Sultamicillin is reported as an ingredient of Bactesul in the following countries:
International Drug Name Search
Tylosin Phosphate may be available in the countries listed below.
Tylosin Phosphate (BANM) is also known as Tylosin (Rec.INN)
International Drug Name Search
Glossary
BANM | British Approved Name (Modified) |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Aspirine Duo may be available in the countries listed below.
Acetylsalicylic Acid is reported as an ingredient of Aspirine Duo in the following countries:
Caffeine is reported as an ingredient of Aspirine Duo in the following countries:
International Drug Name Search
Aknefug Iso may be available in the countries listed below.
Isotretinoin is reported as an ingredient of Aknefug Iso in the following countries:
International Drug Name Search
Ketoconazol Hersil may be available in the countries listed below.
Ketoconazole is reported as an ingredient of Ketoconazol Hersil in the following countries:
International Drug Name Search
Lipantil Supra may be available in the countries listed below.
Fenofibrate is reported as an ingredient of Lipantil Supra in the following countries:
International Drug Name Search
Factor IX Fraction may be available in the countries listed below.
Factor IX Fraction (BAN) is also known as Prothrombin Complex, human (Ph. Eur.)
International Drug Name Search
Glossary
BAN | British Approved Name |
Ph. Eur. | European Pharmacopoeia |
Prednicortil may be available in the countries listed below.
Prednisolone 21-acetate (a derivative of Prednisolone) is reported as an ingredient of Prednicortil in the following countries:
International Drug Name Search
Sufentanil Mylan may be available in the countries listed below.
Sufentanil citrate (a derivative of Sufentanil) is reported as an ingredient of Sufentanil Mylan in the following countries:
International Drug Name Search
Plus Kalium retard may be available in the countries listed below.
Potassium Chloride is reported as an ingredient of Plus Kalium retard in the following countries:
International Drug Name Search
N-Butil Bromuro Hioscina may be available in the countries listed below.
Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of N-Butil Bromuro Hioscina in the following countries:
International Drug Name Search
Infracyanine may be available in the countries listed below.
Indocyanine Green is reported as an ingredient of Infracyanine in the following countries:
International Drug Name Search
In the US, Neupro (rotigotine systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease.
US matches:
Rotigotine is reported as an ingredient of Neupro in the following countries:
International Drug Name Search
Obecirol may be available in the countries listed below.
Budesonide is reported as an ingredient of Obecirol in the following countries:
International Drug Name Search
Antalisin may be available in the countries listed below.
Ibuprofen lysine (a derivative of Ibuprofen) is reported as an ingredient of Antalisin in the following countries:
International Drug Name Search
Metformine may be available in the countries listed below.
Metformine (DCF) is known as Metformin in the US.
International Drug Name Search
Glossary
DCF | Dénomination Commune Française |
Spirocort may be available in the countries listed below.
Budesonide is reported as an ingredient of Spirocort in the following countries:
International Drug Name Search
Finalgel Sport may be available in the countries listed below.
Piroxicam is reported as an ingredient of Finalgel Sport in the following countries:
International Drug Name Search
Neo Cutigenol may be available in the countries listed below.
Chlorhexidine diacetate (a derivative of Chlorhexidine) is reported as an ingredient of Neo Cutigenol in the following countries:
Retinol palmitate (a derivative of Retinol) is reported as an ingredient of Neo Cutigenol in the following countries:
International Drug Name Search
Kanamycin Sanbe may be available in the countries listed below.
Kanamycin sulfate (a derivative of Kanamycin) is reported as an ingredient of Kanamycin Sanbe in the following countries:
International Drug Name Search
Budesonal may be available in the countries listed below.
Budesonide is reported as an ingredient of Budesonal in the following countries:
International Drug Name Search
Depalgos may be available in the countries listed below.
Oxycodone hydrochloride (a derivative of Oxycodone) is reported as an ingredient of Depalgos in the following countries:
Paracetamol is reported as an ingredient of Depalgos in the following countries:
International Drug Name Search
Amiodarone Qualimed may be available in the countries listed below.
Amiodarone hydrochloride (a derivative of Amiodarone) is reported as an ingredient of Amiodarone Qualimed in the following countries:
International Drug Name Search
The following drugs and medications are in some way related to, or used in the treatment of Dermatofibrosarcoma Protuberans. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Naprodev may be available in the countries listed below.
Naproxen sodium salt (a derivative of Naproxen) is reported as an ingredient of Naprodev in the following countries:
International Drug Name Search
In the US, Cotrim (sulfamethoxazole/trimethoprim systemic) is a member of the following drug classes: miscellaneous antibiotics, sulfonamides and is used to treat Acne, Bacterial Infection, Bacterial Skin Infection, Bronchitis, Diverticulitis, Epiglottitis, Granuloma Inguinale, Infection Prophylaxis, Kidney Infections, Melioidosis, Meningitis, Nocardiosis, Otitis Media, Pneumocystis Pneumonia, Pneumocystis Pneumonia Prophylaxis, Pneumonia, Prevention of Bladder infection, Prostatitis, Shigellosis, Sinusitis, Toxoplasmosis, Toxoplasmosis - Prophylaxis, Traveler's Diarrhea, Upper Respiratory Tract Infection and Urinary Tract Infection.
US matches:
Sulfamethoxazole is reported as an ingredient of Cotrim in the following countries:
Trimethoprim is reported as an ingredient of Cotrim in the following countries:
International Drug Name Search
Cholspas Pipenzolat may be available in the countries listed below.
Pipenzolate Bromide is reported as an ingredient of Cholspas Pipenzolat in the following countries:
International Drug Name Search
Tiparol Retard may be available in the countries listed below.
Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Tiparol Retard in the following countries:
International Drug Name Search
Generic Name: oxycodone (Oral route)
ox-i-KOE-done hye-droe-KLOR-ide
Oxycodone hydrochloride is an opioid agonist and a Schedule II controlled substance with an abuse potential similar to morphine. Patients should be assessed for their clinical risks for opioid abuse or addiction prior to being prescribed opioids. Oxycodone hydrochloride controlled-release tablets are indicated for continuous, around the clock analgesia for an extended period of time; not for use on an as needed basis. The 60 mg and 80 mg tablets, a single dose greater than 40 mg, or a total daily dose greater than 80 mg, are only for use in opioid-tolerant patients as they may cause fatal respiratory depression when administered to patients who are not tolerant to the respiratory depressant effects of opioids. Oxycodone hydrochloride controlled-release tablets must be swallowed whole to avoid a rapid release of the drug which can be potentially fatal. Concomitant use with CYP3A4 inhibitors may result in an increase in oxycodone plasma concentrations and may cause potentially fatal respiratory depression .
In the U.S.
In Canada
Available Dosage Forms:
Therapeutic Class: Analgesic
Chemical Class: Oxycodone
Oxycodone is used to relieve moderate to severe pain. It belongs to the group of medicines called narcotic analgesics (pain medicines). Oxycodone acts on the central nervous system (CNS) to relieve pain.
When oxycodone is used for a long time, it may become habit-forming, causing mental or physical dependence. However, people who have continuing pain should not let the fear of dependence keep them from using narcotics to relieve their pain. Mental dependence (addiction) is not likely to occur when narcotics are used for this purpose. Physical dependence may lead to withdrawal side effects if treatment is stopped suddenly. However, severe withdrawal side effects can usually be prevented by gradually reducing the dose over a period of time before treatment is stopped completely.
This medicine is available only with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of oxycodone in the pediatric population. Safety and efficacy have not been established.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of oxycodone in the elderly. However, elderly patients are more likely to have age-related liver or kidney problems, which may require caution and an adjustment in the dose for patients receiving oxycodone.
Pregnancy Category | Explanation | |
---|---|---|
All Trimesters | B | Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus. |
Studies in women breastfeeding have demonstrated harmful infant effects. An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following is usually not recommended, but may be unavoidable in some cases. If used together, your doctor may change the dose or how often you use this medicine, or give you special instructions about the use of food, alcohol, or tobacco.
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
This section provides information on the proper use of a number of products that contain oxycodone. It may not be specific to Roxicodone Intensol. Please read with care.
Take this medicine only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. This is especially important for elderly patients, who may be more sensitive to the effects of pain medicines. If too much of this medicine is taken for a long time, it may become habit-forming (causing mental or physical dependence).
This medicine comes with a patient information leaflet. Read and follow these instructions carefully. Ask your doctor if you have any questions.
Oxycodone extended-release tablets should only be used by patients who have already been taking narcotic pain medicines, also called opioids. These patients are called opioid-tolerant. If you are uncertain whether or not you are opioid-tolerant, check with your doctor before using this medicine.
Measure the oral liquid concentrate with the calibrated dropper that comes with the package. Your doctor may have you mix the concentrate with a small amount of liquid or food. Carefully follow the instructions and take the medicine mixture right away.
Measure the oral liquid with a marked measuring spoon, oral syringe, or medicine cup. The average household teaspoon may not hold the right amount of liquid.
Swallow the Oxecta® or OxyContin® tablet whole with water. Do not break, crush, cut, chew, or dissolve it. Do not pre-soak, lick, or wet the tablet before placing it in the mouth. Take one tablet at a time. Also, do not give this medicine through nasogastric or feeding tubes.
Oxycodone extended-release tablets work differently from the regular oxycodone oral solution or tablets, even at the same dose. Do not switch from one brand or form to the other unless your doctor tells you to.
The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
Oxycodone can cause serious unwanted effects if taken by adults who are not used to strong narcotic pain medicines, children, or pets. Make sure you store the medicine in a safe and secure place to prevent others from getting it.
Flush the unused extended-release tablets and immediate-release tablets down the toilet.
It is very important that your doctor check your progress while you are taking this medicine. This will allow your doctor to see if the medicine is working properly and to decide if you should continue to take it.
This medicine will add to the effects of alcohol and other CNS depressants (medicines that can make you drowsy or less alert). Some examples of CNS depressants are antihistamines or medicine for allergies or colds; sedatives, tranquilizers, or sleeping medicine; other prescription pain medicine or narcotics; medicine for seizures or barbiturates; muscle relaxants; or anesthetics, including some dental anesthetics. Check with your doctor before taking any of these medicines while you are using this medicine.
This medicine may be habit-forming. If you feel that the medicine is not working as well, do not use more than your prescribed dose. Call your doctor for instructions.
Dizziness, lightheadedness, or fainting may occur when you get up suddenly from a lying or sitting position. Getting up slowly may help lessen this problem. Also, lying down for a while may relieve the dizziness or lightheadedness.
This medicine may make you dizzy, drowsy, or lightheaded. Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are dizzy or not alert.
Using narcotics for a long time can cause severe constipation. To prevent this, your doctor may direct you to take laxatives, drink a lot of fluids, or increase the amount of fiber in your diet. Be sure to follow the directions carefully, because continuing constipation can lead to more serious problems.
If you have been using this medicine regularly for several weeks or longer, do not change your dose or suddenly stop using it without checking with your doctor. Your doctor may want you to gradually reduce the amount you are using before stopping it completely. This may help prevent worsening of your condition and reduce the possibility of withdrawal symptoms, such as abdominal or stomach cramps, anxiety, fever, nausea, runny nose, sweating, tremors, or trouble with sleeping.
Using this medicine while you are pregnant may cause serious unwanted effects in your newborn baby. Tell your doctor right away if you think you are pregnant or if you plan to become pregnant while using this medicine.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Get emergency help immediately if any of the following symptoms of overdose occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: Roxicodone Intensol side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.